Oriola-KD Corporation published the interim report 1 January - 30 September 2015 on Thursday, 22 October 2015 at 8.30 a.m.
President and CEO Eero Hautaniemi’s comments regarding the interim report:
"Swedish businesses net sales increased and operating profit excluding non-recurring items improved from corresponding period in January-September, on a constant currency basis operating profit excluding non-recurring items increased by approximately EUR 2.3 million.
Profitability of the Swedish retail business was supported by increased sales of OTC and traded goods and cost control. Profitability was negatively affected by significant decrease of parallel import from the corresponding period and price cuts set by Swedish authorities in fourth quarter of 2014 and in second quarter of 2015. Positive development of the Swedish wholesale business was supported by the new agreements with pharmaceutical companies signed in 2014 and increased
efficiency. In accordance with our plan, we opened a web shop in Sweden in September. The product assortment of the web shop represents the entire Kronans Apotek pharmacy chain product assortment.
In the Finnish wholesale business we renewed significant long term cooperation agreements with MSD and Orifarm in the third quarter. The result of the Finnish wholesale improved due to increase volume and services sales to pharmaceutical companies.
Oriola-KD's updated strategy, new operating model and long term financial targets were published on 18 August 2015. The new operating model and responsibilities will be effective as of 1 January 2016."